Allercet

Quick links to important sections

Allercet

Selected form

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Allercet

What is Allercet?

Allercet is a medication primarily used to manage symptoms associated with allergic reactions. It belongs to a class of drugs known as second-generation antihistamines, which are designed to provide relief from allergy symptoms while typically causing less drowsiness than older antihistamines.

Mechanism of Action

The active ingredient in Allercet works by blocking the action of histamine, a natural substance in the body that is released during an allergic reaction. When the body encounters an allergen—such as pollen, dust mites, or animal dander—the immune system responds by releasing histamine. This substance binds to specific receptors, leading to common symptoms like sneezing, itching, and watery eyes. By competing for these receptor sites, Allercet helps to prevent and reduce these physiological responses.

Common Uses

Allercet is frequently utilized to address various allergic conditions, including:

  • Seasonal Allergic Rhinitis: Often referred to as hay fever, this involves nasal congestion, sneezing, and an itchy or runny nose triggered by outdoor allergens.
  • Perennial Allergic Rhinitis: Similar to seasonal allergies but occurring year-round, usually caused by indoor triggers like mold or pet hair.
  • Chronic Urticaria: This condition is characterized by the appearance of hives or itchy red bumps on the skin that persist for several weeks or more.

Therapeutic Profile

As a second-generation antihistamine, Allercet is formulated to be more selective in its action. It primarily targets peripheral histamine receptors rather than those in the central nervous system. This selectivity is intended to minimize the sedative effects often associated with allergy medications, allowing individuals to maintain their daily activities while managing their symptoms.

Regulatory References

  1. Cetirizine - StatPearls - NCBI Bookshelf

What side effects are possible with Allercet?

Possible Side Effects and Safety Information

The safety profile of Allercet (Cetirizine Hydrochloride) is officially structured by regulatory documents based on the frequency and the physiological system affected. Adverse reactions are classified using standard frequency categories derived from clinical trial and post-marketing data.

Frequency and System-Organ Classifications

Adverse reactions are formally listed by government authorities across various System-Organ Classes (SOC), including Nervous system disorders, Gastrointestinal disorders, and Skin and subcutaneous tissue disorders. Some effects may be more evident at the initiation of therapy, such as fatigue, somnolence (drowsiness), and headache, which are officially classified as common in the regulatory documents.

Uncommon effects include paresthesia, pruritus, and abdominal pain. Rare effects (ge 1/10,000 to < 1/1,000) documented in the label include convulsions, tachycardia (fast heartbeat), and liver function abnormalities.

Serious Adverse Reactions and Restrictions

Regulatory sources document very rare (< 1/10,000) serious adverse reactions such as anaphylactic shock/reaction, angioedema, and syncope (fainting). The label also notes that symptoms like intense itching and hives have been reported with a not known frequency following the discontinuation of the medicine.

Safety notes specify that caution is advised in older adults and individuals with renal impairment due to reduced drug clearance. The medicine is formally contraindicated in individuals with severe renal failure (creatinine clearance less than 10 ml/min) and those with a known hypersensitivity to the active substance, its related compounds like hydroxyzine, or any excipients.

Overdose and Emergency Response

Overdose and when to seek help

Immediate professional medical assistance must be sought following any suspected overdosage of Allercet (Cetirizine Hydrochloride). The officially documented overdose profile is defined by a range of effects primarily involving the Central Nervous System. Clinical manifestations may include signs of sedation and profound somnolence, fatigue, and dizziness. Conversely, some cases, particularly in pediatric patients, may present with restlessness, agitation, or tremor. Other documented systemic signs include confusion, tachycardia (increased heart rate), diarrhea, dry mouth, and urinary retention.

In severe overdose situations, the potential for serious outcomes such as stupor and convulsions is noted in regulatory documents. Management is strictly supportive and symptomatic, as the official prescribing information states that no specific antidote is known. Procedures like gastric lavage may be considered shortly after ingestion to limit absorption, though the drug is documented as not being effectively removed by dialysis. Due to potentially reduced clearance, extended monitoring may be required for older adults or patients with pre-existing renal impairment.

Therapeutic Uses of Allercet

What Allercet Treats: Main Uses and Benefits

This medication is commonly used to provide symptomatic relief across the domains of seasonal allergic rhinitis (hay fever) and perennial allergic rhinitis, which manifest year-round. It is also applied in clinical settings marked by the discomfort of Chronic Urticaria (hives) and other related allergic skin conditions. This anti-allergic support helps address the characteristic cluster of symptoms related to heightened physiological activity, including frequent sneezing, a persistent runny nose, nasal itching, itchy and watery eyes, and generalized skin itching (pruritus).


In conditions characterized by periods of heightened symptoms, Allercet assists with managing distressing dermal and respiratory manifestations. It is relevant when supportive symptom management is appropriate, as it offers a key therapeutic advantage by providing long-acting, 24-hour symptom control, supporting sustained relief with minimal interference with daily alertness. This sustained benefit helps patients cope more steadily with chronic or recurrent episodes, contributing to improved comfort during symptomatic periods.

“The primary benefit is assisting with the overall burden of symptoms, helping maintain a sense of stability when allergic manifestations become more noticeable.”


Quick Fact: Relief for Itching

The medication is applied in addressing the intensity of itching related to skin allergies (pruritus) and the ocular discomfort of allergic conjunctivitis.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Allercet

The population eligibility for Allercet (Cetirizine Hydrochloride) is officially determined by age, pre-existing conditions, and chemical sensitivities, as documented by regulatory bodies.

Category Eligibility Rule (Official Basis)
Contraindicated Populations Hypersensitivity to the active substance, excipients, the parent compound hydroxyzine, or any piperazine derivatives. Also, patients with severe renal impairment (CLcr < 10 mL/ min) must not use this medicine.
Age-Group Eligibility Approved for adults and adolescents ge 12 years. Children ge 6 years can use tablets. Liquid formulations are approved for some pediatric patients as young as 6 months. The tablet form is not recommended for children <6 years.
Conditional Use Caution is advised for patients with predisposing factors for urinary retention or those who are epileptic or at risk of convulsions. Dose adjustment is necessary for individuals with moderate renal impairment or combined hepatic and renal impairment.
Pregnancy/Lactation Status Use is advised during pregnancy only if the expected benefit clearly outweighs potential risk. Use is not recommended while breastfeeding.

Connection to the overall eligibility profile

Regulatory documents establish absolute non-eligibility based on chemical allergies and severe organ impairment. The profile also sets explicit age minimums for the different formulations and mandates specific cautions for use in populations with certain comorbidities, ensuring use is only permitted under controlled conditions.

What should I know about interactions with other medicines?

The official regulatory documents define the interaction profile of Allercet (Cetirizine Hydrochloride) based on two primary categories: pharmacodynamic effects and specific pharmacokinetic alterations.

Pharmacodynamic Interactions

The most important documented interaction is additive pharmacodynamic reinforcement. Co-administration with alcohol or other Central Nervous System (CNS) depressants is noted to cause an additive reduction in alertness and potential impairment of performance, as stated in regulatory prescribing information. No substance is formally classified as a prohibited combination or absolute contraindication.

Pharmacokinetic and Absorption

Limited pharmacokinetic (PK) interactions have been reported. Co-administration with Theophylline ( 400 mg once daily) is officially documented to cause a specific 16% decrease in the systemic clearance of cetirizine, which results in increased drug exposure. In contrast, the medicine does not display clinically significant interaction with substances like erythromycin or azithromycin.

Regarding absorption, food does not impact the total drug exposure ( AUC), but it does delay the rate of absorption and reduces the peak plasma concentration ( C max).

Transporter and Clearance Notes

Cetirizine is identified as a P-glycoprotein ( P-gp) substrate, establishing a potential pathway for interaction with P-gp inhibitors. Furthermore, official labels indicate that the systemic clearance of cetirizine is reduced in patients with documented renal or hepatic impairment, a factor that requires careful consideration to manage overall exposure and interaction potential.

Mechanism of Action

Selective Blockade of Peripheral H1 Receptors

Allercet (cetirizine) functions as a selective antagonist at the peripheral Histamine H1-receptor. This action is confined primarily to tissues outside the central nervous system due to the drug's limited passage across the blood-brain barrier. By occupying the H1 receptor, the compound prevents the binding of endogenous histamine, thereby interrupting the signaling cascade that typically follows receptor activation. This antagonism defines the drug's mechanism.

Modulation of Vascular and Neural Cascades

Interruption of the H1 signaling cascade directly modulates resulting physiological processes in the peripheral vascular and sensory neural pathways. In the vascular system, this mechanism restricts the histamine-induced effects of vasodilation and increased capillary permeability. Simultaneously, it limits the activation of H1-mediated sensory nerve signaling. The selective peripheral action allows for H1 receptor modulation with minimal engagement of central neural pathways, shaping the drug's overall system-level physiological profile.

Dosage and Administration Information

Official Administration Guidelines

Allercet (Cetirizine Hydrochloride) is typically administered by the oral route, available in forms such as tablets, syrups, and solutions. An intravenous (IV) formulation is also used in some jurisdictions for acute use in specific hospital settings, such as for acute urticaria.

Standard Adult Dosing

The standard dosing regimen for adults and adolescents 12 years and older is 10 mg, taken once daily. This is the maximum dose recommended over a 24-hour period for the symptomatic relief of allergic rhinitis and chronic urticaria. A starting dose of 5 mg once daily may be considered for individuals with less severe symptoms.

Contextual Intake and Timing

This medication is designed to be taken once daily to provide sustained 24-hour activity. The dose may be taken with or without food; while food may delay the rate of absorption, it does not reduce the total amount of drug absorbed. Solid dosage forms should be swallowed with a glass of liquid, and liquid formulations must be measured using the provided dosing device to ensure accuracy.

Dose Modification for Specific Populations

Dose adjustments are utilized for certain physiological conditions. For adults with moderate to severe renal impairment, the dose or dosing interval is reduced, such as 5 mg once daily or 5 mg once every two days, depending on the severity of kidney function. For older adults (65 years and over), a starting dose of 5 mg once daily is often specified due to the potential for reduced renal clearance. Dose adjustment is generally not necessary for patients with solely hepatic impairment. If a dose is missed, common practice is to take it when remembered, but not to take two doses to compensate.

Recent Clinical Evidence

Research evidence / Overview of Studies for Allercet

Evidence for Use in Seasonal and Perennial Allergic Rhinitis (Hay Fever)

The evidence base relies on short-term and intermediate-term Randomized Controlled Trials (RCTs) and systematic reviews. Research explored how symptoms for both seasonal and year-round allergies change over time. These studies monitored outcomes related to physical discomfort, such as Total Symptom Scores (TSS) and patient-reported changes in Health-Related Quality of Life (HRQL). Long-term effects, however, are not fully established regarding the sustained nature of the findings over follow-up durations exceeding three months across all populations.

Evidence for Use in Chronic Urticaria (Hives)

This compound was studied in research evaluating Chronic Urticaria, a condition characterized by fluctuating manifestations of hives and itching. Studies explored outcomes related to physical discomfort using validated scales, such as the Urticaria Activity Score (UAS). Research examining higher-dose patterns for unresponsive cases was based on smaller sample sizes with varying protocols. There is limited information for long-term outcomes for patients requiring continuous maintenance monitoring over extended periods.

Studies for Ocular Allergy Symptoms (Allergic Conjunctivitis)

Research exploring outcomes related to irritative states of allergic conjunctivitis was evaluated in Phase III randomized, vehicle-controlled clinical trials, often using the controlled Conjunctival Allergen Challenge (CAC) model. Primary outcomes monitored included patient-reported ocular itching and investigator-assessed signs like redness. The limitation is that the majority of data is derived from this short-term, controlled setting, and evidence from real-world symptom burdens is less common.

Research Gaps and Subgroup Evidence

The compound was evaluated in studies across a wide range of patient populations. Specific RCTs monitored outcomes in children and infants aged 6 months and older, contributing to understanding symptom patterns in the youngest patients. However, data for certain groups, such as older adults (aged 65 and older) and those with symptoms resistant to standard approaches, often stem from studies where sample sizes were modest. Comparative evidence is lacking against some other treatments, and follow-up durations were limited in the primary efficacy studies.

Frequently Asked Questions (FAQ)

Common questions about Allercet (FAQ)

Q: What is the expected length of time that Allercet is effective?

Official information indicates that Allercet is designed to provide sustained 24-hour activity to relieve allergy symptoms. Clinical data suggests that the drug is readily absorbed, and effects are generally reported to begin within thirty minutes to an hour after taking the oral dose. The elimination half-life, which measures how long it takes for half the drug to be cleared from the plasma, is approximately 8 to 9 hours.


Q: How does the drug classification of Allercet compare to drugs like fexofenadine?

Allercet (cetirizine) and fexofenadine are both classified as second-generation H₁ antagonists. This classification means the design of these compounds is associated with minimal penetration of the blood-brain barrier, which helps to reduce the possibility of central nervous system effects such as sedation.


Q: Can Allercet affect mental focus, concentration, or reaction time?

Regulatory warnings indicate that Allercet may cause side effects like drowsiness and dizziness. Official warnings note that performance may be impaired, which is relevant when performing tasks that require concentration or operating machinery. Caution is necessary until an individual knows how they respond to the medicine.


Q: What are the typical non-active ingredients found in Allercet tablets?

The inactive ingredients listed on product labels for cetirizine may include excipients such as lactose monohydrate, magnesium stearate, polyvinyl alcohol, titanium dioxide, polyethylene glycol, and starches. These substances are used to give the tablet its structure and ensure stability.


Q: Have clinical trials examined the safety of Allercet in combination with sedative medicines?

Regulatory information warns that taking Allercet with Central Nervous System (CNS) depressants, which includes sedatives, can cause an additive reduction in alertness. Warnings are based on evidence from clinical studies that have examined the known additive effect of cetirizine when used with CNS depressants.


Q: Is Allercet generally intended for short-term or continuous use?

Allercet can be used for both short-term relief and long-term daily use for chronic conditions. However, official regulatory documents note a reported risk that severe itching (pruritus) can occur after discontinuing the medicine following continuous long-term use.


Q: How quickly does the effect of Allercet typically begin after being taken?

Studies and official medical references indicate that the anti-allergic effects of Allercet generally begin to take effect quickly, usually within thirty minutes to an hour after the tablet or liquid is taken by mouth.


Q: Can taking Allercet cause feelings of nervousness or agitation?

While nervousness or agitation are not listed among the most common effects in core documents, post-marketing data has reported these types of side effects in some individuals. Individuals may monitor their response to the medication.


Q: Is it possible for Allercet to cause dizziness or lightheadedness?

Yes, dizziness is listed as a possible side effect in the safety documentation. If this effect is experienced, caution is necessary when driving or operating machinery.


Q: Does Allercet interact with common pain relievers like ibuprofen or acetaminophen?

Official drug interaction guidance indicates that no clinically significant interaction has been reported between Allercet and common pain relievers such as ibuprofen or acetaminophen. Users of multiple medications may consult the official product labeling for a complete list of interaction warnings.


Q: Are there any known interactions between Allercet and specific antidepressant medicines?

Taking Allercet with certain types of antidepressant medicines may increase side effects such as drowsiness, dizziness, and difficulty concentrating. This occurs due to potential additive effects on the central nervous system (CNS).


Q: Can Allercet be taken safely with common over-the-counter cold and flu remedies?

Since many cold and flu remedies contain ingredients that cause drowsiness, the official label warns that taking Allercet with any Central Nervous System (CNS) depressant can lead to an additive reduction in alertness. Caution is advised when combining these types of medications.


Q: Why do official sources sometimes suggest taking Allercet in the evening?

Although the medicine provides 24-hour relief, official guidance suggests taking it in the evening if a user experiences mild drowsiness. This timing may also be suggested if the individual's allergy symptoms are typically more severe at night due to triggers like dust mites.


Q: Is Allercet typically available over the counter, or does it require a prescription?

The active ingredient in Allercet (cetirizine) is widely available as an over-the-counter (OTC) medication. In some specialized formulations or dosages, it may also be available as a prescription drug.


Q: Does Allercet help reduce nasal congestion, or only running nose and itching?

The single-ingredient form of Allercet is indicated for symptoms such as runny nose, sneezing, and itching of the eyes, nose, or throat. It is not indicated for the specific relief of nasal congestion.


Q: Are there any warnings about taking Allercet with certain herbal supplements?

Official guidance advises patients to inform a healthcare provider of any herbal products they are taking. This caution is primarily for supplements that may cause side effects like sleepiness, dry mouth, or difficulty with urination, as Allercet may potentially worsen these effects.


Q: Is Allercet known to cause changes in weight?

Weight changes are generally not listed among the common side effects in the official labeling. However, some evidence has noted an association between the use of the active ingredient (cetirizine) and potential changes in appetite or weight.


Q: Why is Allercet sometimes used specifically for indoor allergies, such as to dust mites?

The official product claims indicate that the medicine is effective for relieving symptoms related to both outdoor and indoor upper respiratory allergies. This includes common indoor triggers such as pet dander and dust mites.


Q: Does Allercet affect the results of allergy skin tests?

Yes, authoritative clinical guidance states that the drug must be temporarily discontinued before allergy skin testing. As an antihistamine, it can suppress the body's natural allergic reaction, which may interfere with the test results.


Q: Is there any evidence regarding Allercet's use for helping with symptoms related to motion sickness?

Research confirms that second-generation antihistamines like Allercet are ineffective for the prevention or treatment of motion sickness.

How should Allercet be stored and disposed of?

Allercet (cetirizine hydrochloride) must be stored under specific conditions to maintain its effectiveness, as required by regulatory labeling. The medicine should be stored at controlled room temperature, typically between 20 C to 25 C (68 F to 77 F), and excessive heat must be avoided. The container should be kept in a dry place, and for certain forms, protection from light is required. For safety, Allercet must be stored out of the sight and reach of children.

Regarding disposal, regulatory guidance states that unused or expired medicine must not be thrown away via wastewater or household trash. The preferred method is to utilize a drug take-back program or consult a pharmacist for correct disposal instructions. If a take-back option is unavailable, the medicine can be mixed with an undesirable substance like coffee grounds before being sealed and placed in the trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Allercet found in:

A-Z Index: